BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31676869)

  • 21. CIC-DUX4 Chromatin Profiling Reveals New Epigenetic Dependencies and Actionable Therapeutic Targets in CIC-Rearranged Sarcomas.
    Bakaric A; Cironi L; Praz V; Sanalkumar R; Broye LC; Favre-Bulle K; Letovanec I; Digklia A; Renella R; Stamenkovic I; Ott CJ; Nakamura T; Antonescu CR; Rivera MN; Riggi N
    Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38275898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: a predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas.
    Asmane I; Watkin E; Alberti L; Duc A; Marec-Berard P; Ray-Coquard I; Cassier P; Decouvelaere AV; Ranchère D; Kurtz JE; Bergerat JP; Blay JY
    Eur J Cancer; 2012 Nov; 48(16):3027-35. PubMed ID: 22682017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary CIC-DUX4 round cell sarcoma of the kidney: A treatment-refractory tumor with poor outcome.
    Bergerat S; Barthelemy P; Mouracade P; Lang H; Saussine C; Lindner V; Jacqmin D
    Pathol Res Pract; 2017 Feb; 213(2):154-160. PubMed ID: 27919577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DUX4 Immunohistochemistry Is a Highly Sensitive and Specific Marker for CIC-DUX4 Fusion-positive Round Cell Tumor.
    Siegele B; Roberts J; Black JO; Rudzinski E; Vargas SO; Galambos C
    Am J Surg Pathol; 2017 Mar; 41(3):423-429. PubMed ID: 27879517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Negative MAPK-ERK regulation sustains CIC-DUX4 oncoprotein expression in undifferentiated sarcoma.
    Lin YK; Wu W; Ponce RK; Kim JW; Okimoto RA
    Proc Natl Acad Sci U S A; 2020 Aug; 117(34):20776-20784. PubMed ID: 32788348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CIC-DUX4 oncoprotein drives sarcoma metastasis and tumorigenesis via distinct regulatory programs.
    Okimoto RA; Wu W; Nanjo S; Olivas V; Lin YK; Ponce RK; Oyama R; Kondo T; Bivona TG
    J Clin Invest; 2019 Jul; 129(8):3401-3406. PubMed ID: 31329165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A t(4;19) pediatric undifferentiated sarcoma with a novel variant of the CIC-DUX4 fusion transcript.
    Krskova L; Stejskalova E; Kabickova E; Mrhalova M; Kodet R
    Pathol Res Pract; 2017 Mar; 213(3):281-285. PubMed ID: 28062084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-grade undifferentiated small round cell sarcoma with t(4;19)(q35;q13.1) CIC-DUX4 fusion: emerging entities of soft tissue tumors with unique histopathologic features--a case report and literature review.
    Haidar A; Arekapudi S; DeMattia F; Abu-Isa E; Kraut M
    Am J Case Rep; 2015 Feb; 16():87-94. PubMed ID: 25683183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spontaneous expression of the CIC::DUX4 fusion oncoprotein from a conditional allele potently drives sarcoma formation in genetically engineered mice.
    Hendrickson PG; Oristian KM; Browne MR; Luo L; Ma Y; Cardona DM; Nash JO; Ballester PL; Davidson S; Shlien A; Linardic CM; Kirsch DG
    Oncogene; 2024 Apr; 43(16):1223-1230. PubMed ID: 38413794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The novel hsa-miR-12528 regulates tumourigenesis and metastasis through hypo-phosphorylation of AKT cascade by targeting IGF-1R in human lung cancer.
    Jeon SH; Yoo JK; Kim CM; Lim ES; Lee SJ; Lee JM; Oh SH; Kim JK
    Cell Death Dis; 2018 May; 9(5):493. PubMed ID: 29712908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CIC-Rearranged Sarcomas: An Intriguing Entity That May Lead the Way to the Comprehension of More Common Cancers.
    Mancarella C; Carrabotta M; Toracchio L; Scotlandi K
    Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histological and immunohistochemical characteristics of undifferentiated small round cell sarcomas associated with CIC-DUX4 and BCOR-CCNB3 fusion genes.
    Yamada Y; Kuda M; Kohashi K; Yamamoto H; Takemoto J; Ishii T; Iura K; Maekawa A; Bekki H; Ito T; Otsuka H; Kuroda M; Honda Y; Sumiyoshi S; Inoue T; Kinoshita N; Nishida A; Yamashita K; Ito I; Komune S; Taguchi T; Iwamoto Y; Oda Y
    Virchows Arch; 2017 Apr; 470(4):373-380. PubMed ID: 28197724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The novel IGF-IR/Akt-dependent anticancer activities of glucosamine.
    Song KH; Kang JH; Woo JK; Nam JS; Min HY; Lee HY; Kim SY; Oh SH
    BMC Cancer; 2014 Jan; 14():31. PubMed ID: 24438088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ewing sarcoma: The clinical relevance of the insulin-like growth factor 1 and the poly-ADP-ribose-polymerase pathway.
    van Maldegem AM; Bovée JV; Peterse EF; Hogendoorn PC; Gelderblom H
    Eur J Cancer; 2016 Jan; 53():171-80. PubMed ID: 26765686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CIC-DUX4 sarcomas.
    Brahmi M; Vanacker H; Macagno N; Tirode F; Dufresne A
    Curr Opin Oncol; 2022 Jul; 34(4):342-347. PubMed ID: 35730520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting the insulin-like growth factor receptor and Src signaling network for the treatment of non-small cell lung cancer.
    Min HY; Yun HJ; Lee JS; Lee HJ; Cho J; Jang HJ; Park SH; Liu D; Oh SH; Lee JJ; Wistuba II; Lee HY
    Mol Cancer; 2015 Jun; 14():113. PubMed ID: 26041671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Undifferentiated small round cell sarcoma with t(4;19)(q35;q13.1) CIC-DUX4 fusion: a novel highly aggressive soft tissue tumor with distinctive histopathology.
    Choi EY; Thomas DG; McHugh JB; Patel RM; Roulston D; Schuetze SM; Chugh R; Biermann JS; Lucas DR
    Am J Surg Pathol; 2013 Sep; 37(9):1379-86. PubMed ID: 23887164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary spinal intramedullary Ewing-like sarcoma harboring CIC-DUX4 translocation: a similar cytological appearance as its soft tissue counterpart but no lobulation in association with desmoplastic stroma.
    Yamada S; Muto J; De Leon JCA; Kumai T; Ito K; Murayama K; Hama N; Nakano Y; Satomi K; Arai Y; Shibata T; Inoue T; Nobusawa S; Ichimura K; Hirose Y; Abe M
    Brain Tumor Pathol; 2020 Jul; 37(3):111-117. PubMed ID: 32449046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathologic Features of a Series of Primary Renal CIC-rearranged Sarcomas With Comprehensive Molecular Analysis.
    Mangray S; Kelly DR; LeGuellec S; Fridman E; Aggarwal S; Shago M; Matoso A; Madison R; Pramanik S; Zhong S; Li R; Lombardo KA; Cramer S; Pressey J; Ross JS; Corona RJ; Bratslavsky G; Argani P; Coindre JM; Somers GR; Ali SM; Yakirevich E
    Am J Surg Pathol; 2018 Oct; 42(10):1360-1369. PubMed ID: 29901569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of insulin-like growth factor-1 receptor in metastatic uveal melanoma and implications for potential autocrine and paracrine tumor cell growth.
    Yoshida M; Selvan S; McCue PA; DeAngelis T; Baserga R; Fujii A; Rui H; Mastrangelo MJ; Sato T
    Pigment Cell Melanoma Res; 2014 Mar; 27(2):297-308. PubMed ID: 24354797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.